Ebstein's Anomaly

Table of Contents

  1. Overview
  2. Embryology and Pathophysiology
  3. Associated Conditions
  4. Clinical Presentations
  5. Diagnosis
  6. Grading and Severity Assessment
  7. Medical Management
  8. Interventional and Surgical Management
  9. Neonatal Ebstein's Anomaly
  10. Prognosis and Long-term Outcomes
  11. Research Papers
  12. Connections
  13. Featured Videos

Overview

Ebstein's anomaly is a rare congenital heart defect in which the tricuspid valve — the valve that separates the right atrium from the right ventricle — is malformed and displaced downward into the right ventricle. Named after Wilhelm Ebstein, who first described it in 1866, the condition occurs in approximately 1 in 20,000 live births and accounts for less than 1% of all congenital heart defects.

The hallmark of the defect is that the septal and posterior leaflets of the tricuspid valve fail to detach properly from the right ventricular wall during fetal development. Instead of sitting at the base of the right ventricle as they should, they remain stuck partway down the ventricular wall. The result is a portion of the right ventricle that functions as an extension of the right atrium — a structure cardiologists call the atrialized right ventricle.

What makes Ebstein's anomaly particularly challenging to manage is its enormous range of severity. At one extreme, it can cause life-threatening cyanosis immediately at birth, with a heart so enlarged it fills the chest cavity. At the other extreme, an adult may reach middle age with a mildly abnormal tricuspid valve found incidentally on an echocardiogram. The degree of leaflet displacement, the size of the functional right ventricle, the severity of tricuspid regurgitation, and the presence of associated defects all determine where a patient falls on this spectrum.

Modern surgical techniques — particularly the cone reconstruction developed by Dr. Jose Pedro da Silva — have dramatically improved outcomes. Most patients with mild to moderate disease lead active lives, though they require lifelong cardiac monitoring and may need intervention as the condition progresses.

Back to Table of Contents

Embryology and Pathophysiology

To understand what goes wrong in Ebstein's anomaly, it helps to know how the tricuspid valve normally forms. During the first trimester, the right ventricle develops from a muscular tube. The future tricuspid valve leaflets initially arise as ridges of compact myocardial tissue embedded in the ventricular wall. Over weeks 5 through 9 of gestation, these ridges undergo a process called delamination — they gradually peel away from the ventricular wall, starting at the ventricular apex and progressing upward toward the base. By week 9, the leaflets should be fully detached and hanging freely at the tricuspid annulus, the ring-shaped junction between the right atrium and right ventricle.

In Ebstein's anomaly, this delamination process fails partway through. The septal leaflet (adjacent to the interventricular septum) and the posterior leaflet remain adherent to the ventricular wall, effectively stuck at some point below where they should be. Only the anterior leaflet, which typically delaminates successfully, is free-moving — and it often grows abnormally large and sail-like in compensation.

This failure of delamination produces a cascade of structural consequences:

The degree to which each of these consequences develops determines the clinical severity of the condition in any individual patient.

Back to Table of Contents

Associated Conditions

Ebstein's anomaly rarely occurs in isolation. Several cardiac and non-cardiac conditions are consistently found alongside it.

Atrial Septal Defect and Patent Foramen Ovale

An opening between the two upper chambers of the heart is present in 80–90% of patients with Ebstein's anomaly. When right atrial pressure is elevated — as it often is in this condition — blood can shunt from right to left through this opening, bypassing the lungs and delivering unoxygenated blood to the body. This produces cyanosis and creates a risk of paradoxical embolism, in which a blood clot forming in the venous system travels to the arterial circulation and can cause stroke.

Wolff-Parkinson-White Syndrome

Approximately 25–30% of patients with Ebstein's anomaly have an extra electrical connection between the atria and ventricles — an accessory pathway (Kent bundle) that bypasses the normal AV node. This accessory pathway is typically located on the right side of the heart. Its presence causes Wolff-Parkinson-White (WPW) syndrome, which predisposes to supraventricular tachycardia (SVT). More dangerously, if atrial fibrillation develops in a patient with WPW, the accessory pathway can conduct impulses at very high rates to the ventricles, potentially triggering ventricular fibrillation and sudden cardiac death. Calcium channel blockers like verapamil are contraindicated in WPW because they can accelerate conduction through the accessory pathway.

Other Arrhythmias

Even without WPW, Ebstein's anomaly creates a substrate for arrhythmias. The massively enlarged right atrium, combined with the abnormal atrialized RV segment, produces areas of abnormal electrical conduction. Atrial flutter and atrial fibrillation are common as the disease progresses, particularly in adults. Right bundle branch block appears on the ECG of many patients as a consequence of right ventricular structural abnormality.

Other Structural Heart Defects

Less commonly, Ebstein's anomaly occurs together with a ventricular septal defect, pulmonary stenosis, or pulmonary atresia. The combination with pulmonary atresia is particularly severe, as the right ventricle faces both outflow obstruction and volume overload from tricuspid regurgitation.

Risk Factors and Maternal Exposures

The cause of Ebstein's anomaly in most cases is unknown, but several maternal exposures during the first trimester modestly increase risk. Maternal lithium use has historically been associated with a higher incidence — early studies dramatically overstated the risk, but a two- to threefold elevation is still recognized. Maternal diabetes, heavy alcohol consumption during early pregnancy, and certain viral infections during the first trimester have also been implicated. Most cases, however, occur in pregnancies without any identified risk factor.

Back to Table of Contents

Clinical Presentations

The clinical picture of Ebstein's anomaly varies so widely that it is best thought of as a spectrum of disorders rather than a single presentation. Age at diagnosis roughly correlates with severity.

Fetal and Neonatal Presentation

The most severe forms are detected before birth. On fetal echocardiography, a massively enlarged heart filling most of the chest cavity — with a cardiothoracic ratio above 0.65 — signals extreme danger. Some affected fetuses develop hydrops fetalis (generalized fluid accumulation throughout the body), which often leads to fetal death. Survivors born with severe Ebstein's may develop functional pulmonary atresia in the first hours of life: even if the pulmonary valve is anatomically open, the tiny, poorly contractile right ventricle cannot generate enough pressure to push blood through the lungs against the normally elevated pulmonary vascular resistance of the newborn period. The result is severe cyanosis requiring immediate intervention. Neonatal Ebstein's carries the highest mortality of any presentation.

Pediatric Presentation

Children who survive infancy without severe symptoms typically come to attention during childhood with exercise intolerance, episodes of cyanosis with exertion, failure to thrive, or palpitations from SVT. The enlarged heart is often detected on a chest X-ray taken for another reason. These children generally require evaluation by a specialized pediatric cardiac team and may need surgical intervention, though many can be managed conservatively through childhood with appropriate monitoring.

Adult Presentation

A substantial number of patients reach adulthood without diagnosis or with only mild symptoms. Adults with Ebstein's anomaly may present with any of the following:

Sudden cardiac death from arrhythmia remains a risk throughout adulthood, particularly in those with WPW or poorly controlled atrial fibrillation. Annual or biannual cardiac evaluation is recommended for all adults with known Ebstein's anomaly.

Back to Table of Contents

Diagnosis

Diagnosing Ebstein's anomaly involves several complementary imaging and electrical studies, each contributing different information about anatomy and function.

Echocardiography

Echocardiography (ultrasound of the heart) is the primary diagnostic tool and provides the most complete picture. The key diagnostic finding is apical displacement of the septal tricuspid leaflet: the leaflet's attachment point is displaced more than 8 mm per square meter of body surface area (or more than 20 mm in absolute terms in adults) toward the apex of the right ventricle, rather than sitting at the atrioventricular junction. Additional echocardiographic findings include:

Chest X-Ray

The plain chest X-ray often provides the first clue. Massive cardiomegaly producing a box-shaped or water-bottle silhouette — the heart occupying more of the chest than normal — combined with clear lung fields (because pulmonary blood flow is reduced) is a classic pattern that immediately raises suspicion for Ebstein's anomaly. In the most severe cases the enlarged heart fills nearly the entire chest cavity.

Electrocardiogram

The ECG in Ebstein's anomaly shows several characteristic findings. Right bundle branch block is very common, reflecting the abnormal right ventricular anatomy. Giant P waves — sometimes called "Himalayan P waves" for their towering height — reflect the markedly enlarged right atrium. In patients with WPW, delta waves (slurred upstroke of the QRS complex) and a short PR interval are visible. Prolonged PR interval and atrial fibrillation may also be seen.

Cardiac MRI

Cardiac magnetic resonance imaging provides precise three-dimensional measurements of right ventricular volumes and function that echocardiography cannot always achieve due to the irregular shape of the RV. MRI is particularly valuable for surgical planning — it can quantify exactly how much functional right ventricular myocardium is available and assess the degree of atrialization. It also characterizes myocardial tissue, detecting fibrosis that may indicate arrhythmia risk.

Electrophysiology Study

In patients with documented or suspected WPW, an invasive electrophysiology study is often performed before cardiac surgery. A catheter is threaded into the heart to precisely map the location of the accessory pathway, assess its conduction properties, and perform catheter ablation — destroying the pathway with radiofrequency energy. Ablation of the accessory pathway eliminates WPW-related arrhythmia risk and is generally recommended before elective cardiac surgery, though the distorted anatomy in Ebstein's makes right-sided pathway ablation technically more challenging than usual.

Back to Table of Contents

Grading and Severity Assessment

Because Ebstein's anomaly spans such a wide clinical spectrum, several classification systems help stratify patients and guide management decisions.

Carpentier Classification

The most widely used surgical classification, developed by French cardiac surgeon Alain Carpentier, divides Ebstein's anomaly into four types based on anatomy:

Echocardiographic Severity Scoring

Numerical scoring systems based on echocardiographic measurements — including the ratio of right heart area to total heart area, the degree of leaflet displacement, and the severity of tricuspid regurgitation — help predict outcomes and guide timing of intervention. A widely used threshold is a right heart to total cardiac area ratio above 0.5, which identifies patients at higher surgical risk.

Functional Assessment

Exercise stress testing provides objective measurement of exercise capacity and cardiopulmonary reserve. NYHA functional class (I through IV) reflects symptom burden. Formal cardiopulmonary exercise testing with measurement of peak VO2 (maximal oxygen consumption) is used both for prognostication and to time surgical intervention — a declining exercise capacity is a strong indication to proceed with repair even in a patient still in relatively good functional class.

Back to Table of Contents

Medical Management

Medical therapy in Ebstein's anomaly is largely directed at managing symptoms and complications rather than correcting the underlying anatomical problem. It is appropriate for patients with mild to moderate disease and as a bridge to surgery in those awaiting intervention.

Heart Failure Symptoms

Diuretics reduce fluid overload and relieve symptoms of right heart failure such as leg swelling and abdominal congestion. Digoxin may improve right ventricular contractility in selected patients and assists in rate control of atrial arrhythmias in patients without WPW. Salt and fluid restriction helps prevent fluid accumulation.

Arrhythmia Management

Arrhythmia management in Ebstein's anomaly requires careful attention to the potential presence of WPW. Beta-blockers are generally safe for rate control in atrial fibrillation when WPW is absent and are first-line for SVT prevention. Antiarrhythmic medications such as flecainide or amiodarone may be needed for recurrent SVT or atrial fibrillation.

A critical caution: calcium channel blockers (verapamil, diltiazem) are contraindicated when WPW is present. These drugs slow conduction through the AV node but leave the accessory pathway unaffected — or may even enhance its conduction. During atrial fibrillation in a WPW patient, the accessory pathway can then conduct very rapid impulses directly to the ventricles, precipitating ventricular fibrillation. Any patient with Ebstein's anomaly who has not had WPW formally excluded by ECG and, if necessary, electrophysiology study should be treated with extreme caution regarding AV-nodal blocking agents.

Anticoagulation

Patients with atrial fibrillation and those with right-to-left shunting through an ASD are at risk for thromboembolic events, including stroke from paradoxical embolism. Anticoagulation with warfarin or a direct oral anticoagulant is indicated in these patients, with decisions guided by the CHA2DS2-VASc score and individual bleeding risk profile.

Activity and Prophylaxis

Patients are generally advised to avoid activities that produce prolonged Valsalva-maneuver effects (heavy straining), which can transiently increase right-to-left shunting and reduce venous return. Patients with surgically unrepaired defects, or with residual defects after repair, require prophylactic antibiotics before dental and invasive procedures to reduce the risk of infective endocarditis.

Back to Table of Contents

Interventional and Surgical Management

Surgery for Ebstein's anomaly has undergone a revolution over the past two decades. The modern approach centers on repairing rather than replacing the tricuspid valve, preserving native tissue and avoiding the complications of prosthetic valves in a young patient population.

Catheter Ablation of Accessory Pathways

When WPW is present, catheter-based radiofrequency ablation of the accessory pathway is typically recommended before cardiac surgery. Ablation eliminates the risk of pre-excited atrial fibrillation and sudden cardiac death, and prevents the need for intraoperative electrophysiology work during an already complex cardiac procedure. The distorted anatomy of Ebstein's anomaly can make right-sided pathway ablation technically challenging, and success rates at experienced centers are good though somewhat lower than for typical WPW.

Indications for Surgery

Surgical intervention is recommended when any of the following are present:

Cone Reconstruction

The cone reconstruction, developed by Brazilian cardiac surgeon Jose Pedro da Silva and introduced in 2007, represents the most significant advance in surgical treatment of Ebstein's anomaly in decades. The technique works by fully mobilizing the tricuspid leaflet tissue — including the adherent septal and posterior leaflets that are freed from the ventricular wall — and reattaching them in a cone-shaped configuration around the full circumference of the true tricuspid annulus. This recreates a functional valve that sits where it should, eliminates the atrialized RV segment, and achieves coaptation of all three leaflet components.

Long-term results from the Mayo Clinic series — which has performed more than 235 cone repairs — show excellent hemodynamic results with good durability. Ten-year survival exceeds 85%, and the majority of patients have mild or no tricuspid regurgitation after surgery. The procedure is technically demanding and is best performed at high-volume centers with experience in adult congenital heart surgery.

Tricuspid Valve Replacement

When the tricuspid leaflet tissue is too scarce, too distorted, or too scarred to support a cone reconstruction, the valve is replaced with a prosthesis. Bioprosthetic (tissue) valves are generally preferred over mechanical valves in the tricuspid position, as they do not require lifelong anticoagulation and mechanical valves in the tricuspid position carry higher thrombosis risk. Valve replacement is associated with slightly higher perioperative risk and requires eventual re-operation when the bioprosthesis wears out.

Concurrent Procedures

Cardiac surgery for Ebstein's anomaly typically includes closure of the ASD or PFO at the same operation. In patients with atrial fibrillation, a concurrent maze procedure — a surgical technique that creates lesion lines in the atrial tissue to interrupt reentrant circuits responsible for AF — may be performed to restore sinus rhythm. In selected patients with WPW not amenable to catheter ablation, the accessory pathway can be surgically divided.

Cardiac Transplantation

For patients with Carpentier Type D anatomy (near-complete atrialization), end-stage right heart failure, or complex anatomy deemed unsuitable for reconstruction, cardiac transplantation may be the best option. Transplantation eliminates both the structural and arrhythmic components of the disease but carries the lifelong burden of immunosuppression and associated risks.

Back to Table of Contents

Neonatal Ebstein's Anomaly

Neonatal Ebstein's anomaly occupies a special category because its physiology, management, and outcomes differ fundamentally from the disease in older patients. It represents the most dangerous end of the spectrum and requires care at specialized centers with dedicated neonatal cardiac surgery programs.

Transitional Circulation and Functional Pulmonary Atresia

The challenge in newborns with severe Ebstein's anomaly is the combination of a critically small functional right ventricle and the high pulmonary vascular resistance that is normal immediately after birth. Before birth, the fetal circulation bypasses the lungs through connections that close after delivery. In a normal newborn, pulmonary resistance falls within the first hours and days of life, allowing the right ventricle to pump blood through the lungs. In severe Ebstein's anomaly, the right ventricle may be so small and poorly contractile that even after pulmonary resistance falls, it cannot generate adequate pressure. Blood backs up in the right atrium and shunts right-to-left through the foramen ovale, causing severe cyanosis. This "functional pulmonary atresia" can occur even when the pulmonary valve is anatomically open.

Starnes Palliation

For neonates who cannot be stabilized and are not candidates for early repair, the Starnes palliation procedure offers a bridge to later definitive surgery. In this operation, the tricuspid valve orifice is patched closed, converting the heart to a functional single ventricle (left ventricle). Blood flow to the lungs is provided by a systemic-to-pulmonary arterial shunt (Blalock-Taussig-Thomas shunt). This reduces volume overload on the right heart, stabilizes the circulation, and allows the child to grow before more definitive single-ventricle palliation (Fontan pathway) is undertaken at a later age.

Risk Stratification and Specialized Care

Fetal echocardiography can identify severely affected fetuses before birth. A cardiothoracic ratio above 0.65 on fetal echo is associated with extremely poor prognosis without intervention. Delivery should be planned at a center capable of immediate cardiac intervention, including neonatal cardiac surgery and extracorporeal membrane oxygenation (ECMO) if needed. The decision to pursue aggressive intervention, palliation, or comfort care in the most severely affected neonates involves close discussion between the cardiac team, neonatologists, and the family.

Back to Table of Contents

Prognosis and Long-term Outcomes

The prognosis for Ebstein's anomaly has improved dramatically with advances in surgical technique, arrhythmia management, and long-term follow-up protocols. What was once a condition associated with early death or severe disability is now manageable as a lifelong chronic condition for most patients.

Surgical Outcomes

Data from the Mayo Clinic — which has one of the largest surgical series for Ebstein's anomaly in the world — show that cone reconstruction achieves 10-year survival rates exceeding 85%. The majority of patients have mild or no tricuspid regurgitation after cone repair, with good functional capacity. Re-intervention rates of 10–20% at 10 years reflect both the complexity of the underlying anatomy and the durability demands placed on repaired valves in young patients who live for decades. Tricuspid valve replacement, when necessary, provides reliable symptom relief but carries the long-term burden of prosthetic valve management — bioprosthetic valves require replacement at an average of 10–15 years.

Arrhythmia After Surgery

Surgical repair corrects the structural problem but does not completely eliminate arrhythmia risk. The enlarged, scarred right atrium retains an arrhythmic substrate even after tricuspid repair. Atrial fibrillation and atrial flutter remain common after surgery and require continued medical management. Patients who had WPW preoperatively may have residual accessory pathways or develop new arrhythmias. Lifelong electrocardiographic surveillance and periodic Holter monitoring are recommended for all patients after surgical repair.

Pregnancy and Reproduction

Women with Ebstein's anomaly can achieve successful pregnancies, but the increased cardiac demands of pregnancy represent a significant physiological stress. The hormonal changes of pregnancy cause fluid retention, increased cardiac output requirements, and changes in clotting that can precipitate arrhythmias or worsen heart failure. Women with mild disease and no cyanosis generally tolerate pregnancy well with appropriate monitoring. Those with severe disease, significant cyanosis, or prior surgical repair require management by a specialized cardio-obstetric team throughout pregnancy and delivery. Rates of fetal loss and preterm birth are elevated compared to the general population. There is a modestly increased risk that the offspring of women with Ebstein's anomaly will themselves have congenital heart disease — estimated at approximately 5%, substantially higher than the general population risk of about 0.8%.

Living Well with Ebstein's Anomaly

With appropriate specialist follow-up, most patients with Ebstein's anomaly lead productive lives into middle age and beyond. The keys to good long-term outcomes include regular cardiology follow-up at a center with adult congenital heart disease expertise, prompt treatment of arrhythmias, timely surgical intervention when indicated rather than waiting until symptoms are severe, and avoidance of medications that can be dangerous in the setting of WPW. The Adult Congenital Heart Association (ACHA) provides peer support and resources for patients navigating lifelong congenital heart disease.

Back to Table of Contents

Research Papers

  1. Attenhofer Jost CH, Connolly HM, Dearani JA, Edwards WD, Danielson GK. Ebstein's anomaly. Circulation. 2007;115(2):277–285. PMID: 17228022. PubMed
  2. da Silva JP, Baumgratz JF, da Fonseca L, et al. The cone reconstruction of the tricuspid valve in Ebstein's anomaly. J Thorac Cardiovasc Surg. 2007;133(1):215–223. PMID: 17198815. PubMed
  3. Danielson GK, Driscoll DJ, Mair DD, Warnes CA, Oliver WC Jr. Operative treatment of Ebstein's anomaly. J Thorac Cardiovasc Surg. 1992;104(5):1195–1202. PMID: 1434706. PubMed
  4. Dearani JA, Said SM, Burkhart HM, et al. Strategies for tricuspid re-repair in Ebstein malformation using the cone technique. Ann Thorac Surg. 2013;96(1):202–210. PMID: 23673069. PubMed
  5. Starnes VA, Pitlick PT, Bernstein D, Griffin ML, Choy M, Shumway NE. Ebstein's anomaly appearing in the neonate. J Thorac Cardiovasc Surg. 1991;101(6):1082–1087. PMID: 2041002. PubMed
  6. Holst KA, Dearani JA, Said S, et al. Improving results of surgery for Ebstein anomaly: where are we after 235 cone repairs? Ann Thorac Surg. 2018;105(1):160–168. PMID: 29032101. PubMed
  7. Lui RC, Levin MG, Siu SC, Silversides CK, Oechslin E. Ebstein anomaly: a review for the internist. CMAJ. 2016;188(10):727–733. PMID: 27151534. PubMed
  8. Yalonetsky S, Tobler D, Greutmann M, et al. Cardiac magnetic resonance imaging and the assessment of Ebstein anomaly in adults. Am J Cardiol. 2011;107(5):767–773. PMID: 21247546. PubMed
  9. Reich JD, Auld D, Hulse E, Sullivan K, Campbell R. The pediatric radiofrequency ablation registry's experience with Ebstein's anomaly. Pediatric EP Society. J Cardiovasc Electrophysiol. 1998;9(12):1370–1377. PMID: 9869523. PubMed
  10. Celermajer DS, Bull C, Till JA, et al. Ebstein's anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol. 1994;23(1):170–176. PMID: 8277678. PubMed
  11. Earing MG, Cetta F, Driscoll DJ, Mair DD, Hodge DO, Danielson GK. Long-term follow-up of patients after surgical treatment for Ebstein anomaly. Mayo Clin Proc. 2005;80(4):542–546. PMID: 15819296. PubMed
  12. Driscoll DJ, Mottram CD, Danielson GK. Spectrum of exercise intolerance in 45 patients with Ebstein's anomaly and observations on exercise tolerance in 11 patients after surgical repair. J Am Coll Cardiol. 1988;11(4):831–836. PMID: 3346540. PubMed

Search PubMed for more: Ebstein anomaly | Cone reconstruction | Tricuspid valve repair in Ebstein's

Back to Table of Contents

Connections